GlobeNewswire

4DMT to Participate in Upcoming Investor Conferences
03/11/2026
EMERYVILLE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
03/11/2026
ORLANDO, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, [...]
Santé des enfants Canada publie Le meilleur départ, une feuille de route nationale pour transformer les systèmes de santé des enfants et des jeunes
03/11/2026
Le meilleur départ présente une vision à l’intention des gouvernements fédéral, provinciaux et territoriaux pour améliorer la qualité et l’équité des soins de santé aux 8,6 millions d’enfants au Canada OTTAWA, Ontario, [...]
Children’s Healthcare Canada releases Start Strong, a National Playbook to Transform Child and Youth Health Systems
03/11/2026
Start Strong sets out a vision for federal, provincial, and territorial governments to deliver better, more equitable healthcare to Canada's 8.6 million children OTTAWA, Ontario, Nov. 03, 2026 (GLOBE NEWSWIRE) -- [...]
Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting
03/11/2026
Two Invited Presentations Showcase Clinical Progress in Solid Tumors and Allogene's Broader Vision in Oncology and Autoimmune Disease Preclinical Poster Features Next-Generation DLL3/CD70 Dual CAR T Product Candidate [...]
Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx
03/11/2026
Potential to pay as little as $0 per fill for VOQUEZNA, plus free home delivery and prior authorization support, makes it simpler for GERD patients to get the medicine their doctor prescribed A Media Snippet [...]
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
03/11/2026
MONTREAL and CHARLOTTE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test
03/11/2026
Collaboration closes the loop between AI drug design and human biology: Chemveda designs and makes the molecules, VivoSim’s NAMkind™ 3D human liver and intestine models show which ones are safe to advance, in weeks [...]
FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients
03/11/2026
DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure [...]
Celcuity To Participate in Upcoming Investor Conferences
03/11/2026
MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, [...]
Sofwave Medical Reports Third Quarter 2026 Financial Results and Business Highlights
03/11/2026
Third quarter revenue of $28.5M, +35% year-over-year growth; IFRS gross margin of 76.6% Third quarter usage fee revenue of $13.3M, +60% year-over-year growth First nine months revenue of $82.9M, +41% year-over-year [...]
Vivos Inc. Announces Expansion of IsoPet® Animal Cancer Division with Four New Veterinary Clinics Across the United States
03/11/2026
Kennewick, WA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, is pleased to announce [...]
OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30
03/11/2026
Expansion option exercised within weeks as customer increases data volume to support its derivative data offering MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “ [...]
KFSH Highlights AI’s Role in Patient Experience and Nursing at Economist AI in Health Summit
03/11/2026
LONDON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is participating as platinum sponsor of Economist Enterprise’s AI in Health Summit, taking place on November 4 at the [...]
Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
03/11/2026
New data from the phase 2 trial with EVX-01 to be presented in both an oral and poster session COPENHAGEN, Denmark, November 3, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing [...]
Autumn Reset: PROMIXX Outlines How to Pick a Leak-Proof, Easy-Clean Protein Shaker for the Gym
03/11/2026
Searches for protein shakers climb each autumn as people look for top-rated shaker bottles. Cardiff, United Kingdom, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Two things keep a shaker from smelling: the material and how [...]
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
03/11/2026
Four presentations highlight BriaCell’s Bria-OTS+™ cellular immunotherapy platform and BriaPro’s CD80-based immunotherapy programs In vitro Bria-OTS+ studies demonstrate immune-cell activation and tumor-cell killing [...]
Primmune Therapeutics to Present PRTX007 Phase 1 Pharmacology and Phase 2 INFLECTION-003 Study Design at the SITC 41st Annual Meeting
03/11/2026
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Primmune Therapeutics , a clinical-stage biotech company harnessing the power of the innate and adaptive immune systems, today announced that two abstracts on polvitolimod [...]
Cynet Adds AI Security and Stronger Identity Protection to Unified Attack Path Management Platform
03/11/2026
New release gives security teams and MSPs visibility into shadow AI, AI agents and GenAI services, and brings identity risk and ITDR investigations into one view BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cynet, the [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum